Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks Flozins' impact on heart and kidneys

NCT ID NCT07237451

First seen Nov 19, 2025 · Last updated May 20, 2026 · Updated 22 times

Summary

This study is observing 200 adults with chronic kidney disease and a type of heart failure to see how a class of diabetes drugs called flozins affects their heart and kidney health over time. Researchers will track serious heart events, kidney function decline, and death. The goal is to better understand the benefits of these drugs in this specific patient group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE PRESERVED EJECTION FRACTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Dr. C.I. Parhon Hospital in Iasi

    RECRUITING

    Iași, Romania

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.